Metabolic dysfunction-associated fatty liver disease (commonly known as MAFLD) impacts
global health in epidemic proportions, and the resulting morbidity, mortality and economic …

Abstract Background Amiodarone belongs to Class-III anti-arrhythmic drugs. It is one of the
most effective anti-arrhythmic drugs used to treat or prevent several types of arrhythmias …

Лекарственно-ассоциированная жировая болезнь печени (ЛЖБП) это группа
осложнений фармакотерапии, распространенность которых составляет около 10% от …

Background Patients with Fontan circulation are known to be at high risk for developing
atrial tachyarrhythmias (AAs). Our objective was to examine the efficacy and safety of …

Small studies suggest that amiodarone is a weak inhibitor of cytochrome P450 (CYP) 2D6.
Inhibition of CYP2D6 leads to increases in concentrations of drugs metabolized by the …

Objectives The aim of the study was to assess if an association exists between cirrhosis and
herpes zoster in Taiwan. Methods A retrospective cohort study was designed to analyse the …

Drug-induced fatty liver disease (DIFLD) covers a group of adverse drug reactions whose
prevalence accounts for about 10% of all adverse reactions. The aim of this review was to …

This chapter examines two medications of special interest in the practice of both cardiology
and hepatology and thoroughly discusses their effects on hepatic function. They are …

Amiodarone (AMD) is an antiarrhythmic drug that induces idiosyncratic toxicity.
Environmental pollutants, including heavy metals, could interact with its toxicity by affecting …

Acute liver failure (ALF) is a rare condition that can have a variable clinical course and
potentially fatal outcomes. Medication toxicity is a known etiology, however liver failure …